The clinical performance of Invader® technology and SurePath® when detecting the presence of high-risk HPV cervical infection

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos et al. · The Journal of Pathology · 1999 · 9K citations · Full text

Medicine, Oncology, Pathology +16

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

Núbia Muñóz, F. Xavier Bosch, Sílvia de Sanjosé et al. · New England Journal of Medicine · 2003 · 6.3K citations · Full text

Medicine, Oncology, Pathology +17

The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

Michelle J. Khan, Philip E. Castle, Attila T. Lörincz et al. · JNCI Journal of the National Cancer Institute · 2005 · 1.1K citations · Full text

Medicine, Oncology, Pathology +16

Carcinogenicity of human papillomaviruses

Vincent Cogliano, Robert A. Baan, Kurt Straíf et al. · The Lancet Oncology · 2005 · 694 citations

Medicine, Oncology, Toxicology +12

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

Christine Clavel, Marie Masure, J Bory et al. · British Journal of Cancer · 2001 · 475 citations · Full text

Medicine, Pathology, Cancer Screening +16